Abstract:
shock syndrome-like exanthematous disease and food poisoning. The risk of a secondary or metastatic focus such as endocarditis or other endovascular focus, skeletal and CNS infections and variable abscesses. Usually the presence of secondary infections denote complicated one and it is crucial to successful management of ISA which demand different therapies and follow up these cases. 1 The S. aureus being a gram positive, catalse and coagulase positive furthermore the diagnosis of ISA is based on cultures mostly from normally sterile body sites, often blood. 1 Sometimes there is a clinical suspicious of ISA but cultures are negative or impossible to obtain as in deep abscesses. In patients with bacteraemia it is necessary to have more than one blood samples for culture. Serology against various S. aureus antigens could be useful to differentiate between patients with complicated and uncomplicated infections. Healthy adults have detectable levels against most S. aureus antigens. The antibodies develop during childhood and adult antibody levels are generally reached by age of 15 years. 2 The humeral immune response varies greatly during invasive infections. Hence, the clinical value of diagnosis S. aureus serology is low. This is because of varying sensitivity, specificity and insufficient predictive value of these tests or combination of tests used. It is believed that complicated infections generate a higher antibody response than uncomplicated ones. However, that there is no evidence that any serological assay or combination of assays can distinguish between complicated and uncomplicated S. aureus infections. Sensitivity of patients with S. aureus to variable antibiotics varies with the presence of the MecA gene. [3] [4] However, the reliability of the diagnosis of, for example endocarditis in older studies can be questioned, because of the low use of echocardiogram. The time of sampling is crucial, in some studies samples were collected in the first week after the start of illness showed maximum titer while in other studies sampling during the first week was not accepted. In fact, it has been reported lower levels of antibodies against several antigens in patients with complicated bacteraemia as compared with patients with uncomplicated bacteraemia. 5 Toxic shock syndrome produced by S. aureus can be diagnosed serologically and by determination of specific toxin production from patient's isolate. This organism has acquired resistance to commonly used antibiotics such as; Oxacillin/ Mithicillin, Ciprofloxacin, Fusidin Erythromycin and Vancomycin. [6] [7] [8] [9] [10] [11] [12] The advent of molecular tool PCR (polymerase chain reactions) has been used to detect different resistance genes that affect the treatment of Staph aureus infections. 13, 14, 15 In many countries, the number of patients in the hospital either colonized or infected with MRSA has grown dramatically in the last two decades. Many factors have been incriminated in this phenomenon, in Saudi Arabia factors such as knowledge, attitude and practice have led to the rising of antimicrobial resistance. 16 Zone sizes for S. aureus for Oxacillin antibiotic; Susceptible (>13 mm), Oxacillin Intermediate (11-12 mm) and Oxacillin Resistant (<10 mm). In this study patients presented with S. aureus infections (ISA) were included to assess the clinical profile and drugs sensitivity tests.
Material and Methods
50 patients with detection of Staphylococcus aureus directly from nasal swab specimens and presented with variable infections; respiratory infection, central nervous system infections, urogenital infection, musculoskeletal (Joints) infections and skin infection were selected from Aseer central hospital, Saudi Arabia during the period from Jan 2011-Jun 2011. These samples were undergone variable laboratory procedures mainly; bactech, culture media, antibiotics sensitivity test using diffusion disc test (MIC) and molecular (PCR) for detection of mecA gene. Clinical and laboratory data were recorded in special formats and analyzed by statistical computer program (SPSS).
Collection of samples
The tip of the collection swab was inserted approximately 1 in. (2.56 cm) into the nares and rolled five times in each nostril. Collected specimens were transported and stored at room temperature. Cultures were inoculated and specimens were processed for PCR analysis within 24 hrs of being collected to culture inoculation. Each collection swab was initially inoculated into blood agar. Each sample was examined using the following procedure:
Microbilogical tests
The cultures were carried out on blood agar. The plates were incubated for 24 to 48 hrs. at 35°C and examined for growth. After incubation each plate was examined to observe the characters of colonial morphology, and the effect of the organism on culture media. The colonies that appeared as medium to large, smooth, entire, slightly raised, translucent, most colonies pigmented creamy yellow, most colonies showed beta-hemolysis. Confirmation of Staphylococcus species were conducted using: microscopic examination of gram stained film, 3% catalase testing , coagulase testing and Staph latex agglutination assay from the colonies grown on the cultured plates.
Methods of Antimicrobial Susceptibility Testing
Antimicrobial susceptibility testing methods are divided into types based on the principle applied in each system. 
Müeller-Hinton Agar Medium
Müeller-Hinton agar was prepared from a commercially available dehydrated base according to the manufacturer's instructions. Immediately after autoclaving, allow it to cool in a 45 to 50°C water bath.
Pour the freshly prepared and cooled medium into glass or plastic, flat-bottomed petri dishes on a level, horizontal surface to give a uniform depth of approximately 4 mm. This corresponds to 60 to 70 ml of medium for plates with diameters of 150 mm and 25 to 30 ml for plates with a diameter of 100 mm. The agar medium was allowed to cool to room temperature and, unless the plate is used the same day, stored in a refrigerator (2 to 8°C). Plates were should be used within seven days after preparation and wrapped in plastic to minimize drying of the agar.
Preparation of dried filter paper discs
Whatman filter paper no. 1 was used to prepare discs approximately 6 mm in diameter, which were placed in a Petri dish and sterilized in a hot air oven. The loop used for delivering the antibiotics is made of 20 gauge wire and has a diameter of 2 mm. This delivered 0.005 ml of antibiotics to each disc.
Reading Plates and Interpreting Results
After 16 to 18 hours of incubation, each plate is examined. If the plate was satisfactorily streaked, and the inoculum was correct, the resulting zones of inhibition will be uniformly circular and there will be a confluent lawn of growth. The diameters of the zones of complete inhibition (as judged by the unaided eye) are measured, including the diameter of the disc. Zones are measured to the nearest whole millimeter, using sliding calipers or a ruler, which is held on the back of the inverted petri plate. The petri plate is held a few inches above a black, nonreflecting background and illuminated with reflected light. The sizes of the zones of inhibition are interpreted by referring to the standard table, through 2I (Zone Diameter Interpretative Standards and equivalent Minimum Inhibitory Concentration Breakpoints) of the NCCLS M100-S12.
Polymerase chain reaction (PCR):
A nasal specimen is collected and transport to the laboratory using the recommended swab with Liquid Stuart Medium (refer to Materials Required but not provided). For testing, the swab is placed in sample buffer. The specimen is concentrated and lysed. An aliquot of the lysate is added to PCR reagents which contain the MRSA-specific primers used to amplity the genetic target, if present. The assay also includes an internal control (IC) to detect PCR inhibitory specimens and to confirm the integrity of assay reagents. Leeuwen et al., 1996) 17 . Approximately 5 ng of DNA was added per PCRRR mixture. The mixture consisted of a buffer system containing 10 mM Tris-HCl (pH 9.0), 50 mM KCl, 2.5 mM MgCl2, 0.01% gelatine, and 0.1% Triton X-100. Deoxyribonucleotide triphosphates (0.2 mM; Pharmacia Biotech, Uppsala, Sweden) as well as 0.2 U of Taq polymerase (SuperTaq; HT Biotechnology, Cambridge, United Kingdom) were present in the reaction mixture. Five different primers and combinations thereof were used in the assays. The codes and sequences of the primers (50 pmol of primer per reaction) were as follows: ERIC-1R, 59-ATG TAA GCT CCT GGG GAT TCA C-39; ERIC-2, 59-AAG TAA GTG ACT GGG GTG AGC G-39. The PCR mixture was overlaid with 100 ml of mineral oil to prevent evaporation. Amplification of DNA fragments was performed in a Biomed thermocycler (model 60; Biomed, Theres, Germany) with predenaturation at 948C for 4 min, followed by 40 cycles of 1 min at 948C, 1 min at 258C, and 2 min at 748C. Amplicons were analyzed by agarose gel electrophoresis containing 1% agarose (Hispanagar; Sphaero Q, Leiden, The Netherlands) in 0.53 Tris-borate-EDTA (TBE) in the presence of ethidium bromide (0.3 mg/ml) at a constant current of 100 mA for 3 h.After photography (high-speed sheet film 57; Polaroid).One positive control and one negative control must be included in each assay run on the Smart Cycler®.
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Data Analysis:
Clinical and Laboratory data were recorded in special formats and entered in stat computer program (SPSS) . Descriptive and analytical statistical analysis were performed and final results were plotted in tables.
Results:
Out of 81 positive cases of Staph aureus confirmed by bacteriological test: 50 cases were positive Mec A gene and 31cases were negative by PCR.
The sample size includes diabetics and non diabetics patients. Sensitivity of some antibiotics were tested among them which include; Oxacillin/ Mithicillin, Ciprofloxacin, Fusidin and Erythromycin.
Oxacillin/ Mithicillin in Staph aureus MecA gene positive cases (50) showed: resistant in diabetic patients (13, 26 .0%) and resistant in non diabetic in this group were (37, 74.0%). While no sensitivity in diabetic and non diabetic patients. Oxacillin/ Mithicillin in Staph aureus MecA gene negative cases (31) showed: sensitivity in diabetic patients (5, 16.1%) and in non diabetic in this group were (26, 83.9%)While no resistant in diabetic and non diabetic patients ( Table-I ).
Ciprofloxacin in Staph aureus (MecA gene) positive cases(50) showed: resistant in diabetic patients (9, 18%) and resistant in non diabetic in this group were (22, 44%). While the sensitivity in diabetic and non diabetic patients were 4 (8%) and 15 (30%) respectively. Ciprofloxacin in Staph aureus MecA gene negative cases (31) showed: resistant in diabetic patients (1, 3.2%) and resistant in non diabetic in this group were (12, 38.7%). While the sensitivity in diabetic and non diabetic patients were 4 (12.9%) and 14 (45.2%) respectively (Table-II) .
Fusidin in Staph aureus (MecA gene) positive cases(50) showed: resistant in diabetic patients (7, 14%) and resistant in non diabetic in this group were (20, 40%) . While the sensitivity in diabetic and non diabetic patients were 6 (12%) and 17 (34%) respectively. Fusidin in Staph aureus MecA gene negative cases (31) showed: resistant in diabetic patients (1, 3.2%) and resistant in non diabetic in this group were (7, 22.6%). While the sensitivity in diabetic and non diabetic patients were 4 (12.9%) and 19 (61.3%) respectively (Table-III) .
Erythromycin in Staph aureus ( MecA gene) positive cases (50) showed: resistant in age (0-15) years were (5, 10%), (16-50) years were (16, 32%) and ( ›50 years) were (12, 24%). While sensitivity in same age groups were; 9 (18%), 7 (14%) and 1 (2%) respectively. Erythromycin in Staph aureus (MecA gene) negative cases (31) showed: resistant in age (0-15) years were (6, 19.3%), (16-50) years were (5, 16.1%) and ( ›50 years) were (3, 9.7%). While sensitivity in same age groups were; 9 (2.9%), 6 (19.4 %)and 2 (6.4%) respectively (Table-IV) . 
Discussion:
The final results from this study have shown that the presence of the mecA gene in S. aureus isolates will lead to 100% resistance to Oxacillin/ Mithicillin while the absence of this gene in the isolates will lead to 100% sensitivity to Oxacillin/ Mithicillin irrespective of patients being diabetic or non diabetic. Erythromycin resistance is clearly increased in elder patients in both MecA gene positive and negative patients. The effect of diabetes on drugs sensitivity is clear among skin infections specimens specially the diabetic foot infections. A study conducted in Abha, Saudi Arabia in 1996 aimed at Nasal carriage and antibiotic resistance of Staphylococcus aureus isolates from hospital and nonhospital personnel; showed that No isolate was resistant to vancomycin. Antibiotic resistance rates, for all other antibiotics tested except cephalothin, were significantly higher for strains from hospital personnel (P values < 0.001-0.04) compared to non-hospital adults. The antibiograms were also compared with those of 140 clinical isolates. The rates of resistance of the inpatient strains to all the antibiotics tested were significantly higher than those of hospital nasal carrier strains (P < 0.001-0.05). MRSA was isolated, respectively, from 5.1% and 18.3% of non-hospital and hospital carriers; MRSA carriage rates were 1.3% and 4.7%, respectively, for non-hospital and hospital carriers, and 61% of S. aureus isolates from infected patients were MRSA. Only 8% of non-hospital but 44% of hospital carrier strains were multiply resistant (P < 0.001). 18 Shades and side Abha such as a study conducted in administrator. It was noted that 25 (78.1%) of these carriers were in constant contact with patients in operating theatres, surgical wards or intensive care units. It was not clear whether the carriers were short-or long-term carriers, or whether they were persistent sources of methicillin-resistant Staphylococcus aureus. 21 Another study conducted in Jordan concerned with antibiotic resistance patterns of mecA-positive Staphylococcus aureus isolates from clinical specimens and nasal carriage; should that The mecA gene was detected in all MRSA isolates in both groups. Most of MRSA isolates were multiresistant to three antibiotic classes (beta-lactams, aminoglycosides, macrolides-lincosamides). This result suggests a serious problem may be encountered in treatment of staphylococcal infections in Jordan. 22 Furthermore a study conducted in the laboratory of King Fahad Hospital, Al-Baha, Kingdom of Saudi Arabia among 2001-2004 aimed at identifying of antibiotic susceptibility tests, plasmid profiles and restriction enzyme analysis of plasmid DNA of methicillin susceptible and resistantStaphylococcus aureus strains isolated from intensive care units; showed at seventy-one MRSA from Turkey were divided into 13 groups by antibiotic sensitivity tests and into 4 groups by plasmid profiles, in which 3rd and 4th groups subdivided into 2 subgroups, and into 5 groups by REAP. The 1st, 2nd, 3rd and 5th groups were subdivided into 2 subgroups. Ten MSSA were divided into 4 groups by antibiotic sensitivity tests, 3 in plasmid profiles and 2 in REAP tests. Twenty-four MRSA strains from KSA were divided into 9 groups by antibiotic sensitivity tests while 93 MSSA strains were divided into 7 groups. 23 While a study conducted in National Medical College Teaching Hospital, Birgunj, Nepal aimed at Nasal carriage rate of methicillin resistant Staphylococcus aureus; should at MRSA prevalence rate were 5.6% and 8.5% in total male and female participants, respectively (P>0.05). Highest MRSA prevalence rate was among health-care personnel (10.0%), followed by visitors/patient attendants (8.2%) and the patients (3.2%) (P>0.05). All MRSA isolates were resistant to Ampicillin, followed by Cephalexin (37.5%), Ciprofloxacin (37.5%), Tetracycline (37.5%), Gentamycin (25.0%), Erythromycin (0.0%) and Vancomycin (0.0%). 24 A study conducted in hospital 
Conclusion:
The drugs resistance towards Staph. aureus infections is clearly increased in Sudi Arabia as in worldwide this resistance involved; beta-lactam droups, vancomycin and aminoglycosides. The new trends in treating Staph aureus infections is a combined therapy specially in serious infections such as pneumonia, meningitis and toxic shock syndrome.
